Phocas Financial Corp. bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 88,568 shares of the company's stock, valued at approximately $6,887,000. Phocas Financial Corp. owned approximately 0.10% of Acadia Healthcare at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ACHC. Headlands Technologies LLC acquired a new position in Acadia Healthcare during the 3rd quarter valued at about $25,000. Point72 Hong Kong Ltd acquired a new position in Acadia Healthcare during the 1st quarter valued at about $38,000. Fifth Third Bancorp boosted its stake in Acadia Healthcare by 25.5% during the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company's stock valued at $52,000 after purchasing an additional 136 shares during the last quarter. Belpointe Asset Management LLC boosted its stake in Acadia Healthcare by 75.7% during the 1st quarter. Belpointe Asset Management LLC now owns 982 shares of the company's stock valued at $71,000 after purchasing an additional 423 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in Acadia Healthcare during the 3rd quarter valued at about $96,000.
Acadia Healthcare Stock Performance
Acadia Healthcare stock traded down $1.80 during trading on Friday, hitting $73.18. The stock had a trading volume of 559,460 shares, compared to its average volume of 592,161. Acadia Healthcare Company, Inc. has a 1 year low of $66.49 and a 1 year high of $87.77. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. The stock's 50 day moving average is $80.10 and its two-hundred day moving average is $77.63. The stock has a market cap of $6.76 billion, a price-to-earnings ratio of -292.72, a price-to-earnings-growth ratio of 2.16 and a beta of 1.31.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.05. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business had revenue of $742.80 million for the quarter, compared to analysts' expectations of $727.60 million. During the same quarter in the previous year, the firm posted $0.70 EPS. The business's revenue for the quarter was up 10.0% compared to the same quarter last year. As a group, analysts predict that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current year.
Insider Buying and Selling at Acadia Healthcare
In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business's stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now owns 46,074 shares of the company's stock, valued at approximately $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 2.80% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on ACHC shares. TheStreet upgraded Acadia Healthcare from a "c" rating to a "b-" rating in a research note on Monday, March 4th. Barclays started coverage on Acadia Healthcare in a research note on Wednesday, March 6th. They issued an "overweight" rating and a $100.00 target price on the stock. Stephens upgraded Acadia Healthcare from an "equal weight" rating to an "overweight" rating and set a $92.00 target price on the stock in a research note on Friday, January 5th. Royal Bank of Canada restated an "outperform" rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Monday, March 4th. Finally, TD Cowen boosted their target price on Acadia Healthcare from $86.00 to $101.00 and gave the stock an "outperform" rating in a research note on Friday, March 1st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $91.22.
Check Out Our Latest Stock Report on Acadia Healthcare
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
